Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Anti-PD-1 antibody in combination with radiotherapy as first-line therapy for unresectable intrahepatic cholangiocarcinoma

Fig. 3

Tumor responses of patients with unresectable iCCA. A Waterfall plots of maximal change of tumor size from baseline in target lesion(s) assessed using RECIST version 1.1. B Swimmer plot of Percent change in tumor dimension of comparable lesion(s) at best responses. C Change of individual tumor burden over time from baseline assessed using RECIST version 1.1. RECIST, Response Evaluation Criteria in Solid Tumors

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us